NT5E and neoplasm: Similarly, another study demonstrated that co-targeting of A2AR and CD73 in conjunction with a DC vaccine successfully reduced tumor growth, prolonged survival, and enhanced specific antitumor immune responses in the same mouse model of breast cancer (186).